# | {{ resultText.questionCol }} | {{ resultText.answerCol }} |
---|---|---|
{{ a.id }} | {{ a.text }} | {{ a.answer }} |
The Patient Health Questionnaire-9 (PHQ-9) is a concise, standardized, evidence-based screening tool that quantifies the frequency of nine core depressive symptoms over the previous two weeks. Each item captures a distinct psychological or somatic domain, enabling a quick yet reliable snapshot of a person’s current mood state and functional impact.
You answer each question by selecting how often the statement applied—ranging from Not at all to Nearly every day. The tool converts those selections into numeric values, sums them automatically, and visualises the total on an interactive gauge. A colour-coded label then translates the score into one of five clinically recognised severity bands.
Easily complete the assessment during a lunch break to track whether recent lifestyle changes are improving your mood or to decide whether it is time to consult a professional. Treat the result as a conversation starter, not a diagnosis, and never ignore persistent suicidal thoughts. Results do not constitute a clinical diagnosis.
The PHQ-9 translates subjective symptom frequency into a numeric score ranging from 0 to 27. Each of the nine items aligns with Diagnostic and Statistical Manual criteria for major depressive disorder. Summing individual item scores yields a quantitative proxy for depression severity that correlates with functional impairment, treatment response, and suicide risk. The questionnaire’s brevity enables repeated use in both primary-care and digital self-help contexts without respondent fatigue.
Score Range | Severity Label |
---|---|
0 – 4 | Minimal |
5 – 9 | Mild |
10 – 14 | Moderate |
15 – 19 | Moderately Severe |
20 – 27 | Severe |
A higher band suggests greater symptom burden and a stronger indication for professional evaluation.
Example: A user answers [1, 2, 1, 0, 2, 1, 1, 0, 0].
Intermediate sum: 1+2+1+0+2+1+1+0+0 = 8.
Total = 8 → Mild severity.
Validity supported by Kroenke et al. (2001), Löwe et al. (2004), and multiple meta-analyses confirming strong sensitivity and specificity for major depressive disorder.
All calculations run locally; no personal data leaves the device, aligning with GDPR principles on data minimisation.
Complete the assessment in four straightforward steps.